Magnetic resonance imaging-guided versus computed tomography-guided stereotactic body radiotherapy for prostate cancer (MIRAGE): Interim analysis of a phase III …
255 Background: Magnetic resonance imaging (MRI) guidance offers several theoretical
advantages over computed tomography (CT) guidance in the context of stereotactic body …
advantages over computed tomography (CT) guidance in the context of stereotactic body …
Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial
Background Stereotactic body radiotherapy (SBRT) is becoming increasingly used in
treating localized prostate cancer (PCa), with evidence showing similar toxicity and efficacy …
treating localized prostate cancer (PCa), with evidence showing similar toxicity and efficacy …
Magnetic resonance imaging–guided vs computed tomography–guided stereotactic body radiotherapy for prostate cancer: the MIRAGE randomized clinical trial
Importance Magnetic resonance imaging (MRI) guidance offers multiple theoretical
advantages in the context of stereotactic body radiotherapy (SBRT) for prostate cancer …
advantages in the context of stereotactic body radiotherapy (SBRT) for prostate cancer …
1.5 T magnetic resonance-guided stereotactic body radiotherapy for localized prostate cancer: preliminary clinical results of clinician-and patient-reported outcomes
Simple Summary The combination of stereotactic body radiotherapy (SBRT) and magnetic
resonance-guided radiation therapy (MRgRT) offers the potential for achieving better tumor …
resonance-guided radiation therapy (MRgRT) offers the potential for achieving better tumor …
A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT)
S Wolfe, MA Diven, AE Marciscano, XK Zhou… - BMC cancer, 2023 - Springer
Background Ultra-hypofractionated regimens for definitive prostate cancer (PCa)
radiotherapy are increasingly utilized due in part to promising safety and efficacy data …
radiotherapy are increasingly utilized due in part to promising safety and efficacy data …
Magnetic resonance image-guided adaptive stereotactic body radiotherapy for prostate cancer: preliminary results of outcome and toxicity
G Ugurluer, B Atalar, T Zoto Mustafayev… - The British journal of …, 2021 - academic.oup.com
Objective: Using moderate or ultra-hypofractionation, which is also known as stereotactic
body radiotherapy (SBRT) for treatment of localized prostate cancer patients has been …
body radiotherapy (SBRT) for treatment of localized prostate cancer patients has been …
A prospective single-arm phase 2 study of stereotactic magnetic resonance guided adaptive radiation therapy for prostate cancer: early toxicity results
AME Bruynzeel, SU Tetar, SS Oei, S Senan… - International Journal of …, 2019 - Elsevier
Purpose Use of stereotactic body radiation therapy (SBRT) is increasing in patients with
localized prostate cancer, but concerns about early and late gastrointestinal (GI) and …
localized prostate cancer, but concerns about early and late gastrointestinal (GI) and …
Acute toxicity comparison of magnetic resonance‐guided adaptive versus fiducial or computed tomography‐guided non‐adaptive prostate stereotactic body …
Background Stereotactic body radiotherapy (SBRT) is gaining wider adoption for prostate
cancer management but there remain significant toxicity risks when delivering prostate …
cancer management but there remain significant toxicity risks when delivering prostate …
A prospective study of Stereotactic Body Radiotherapy (SBRT) with concomitant Whole-Pelvic Radiotherapy (WPRT) for high-risk localized prostate cancer patients …
Simple Summary Magnetic resonance (MR)-guided stereotactic body radiotherapy
(MRgSBRT) with concomitant whole-pelvic nodal radiotherapy (WPRT) represents a novel …
(MRgSBRT) with concomitant whole-pelvic nodal radiotherapy (WPRT) represents a novel …
Magnetic resonance-guided stereotactic radiotherapy for localized prostate cancer: final results on patient-reported outcomes of a prospective phase 2 study
SU Tetar, AME Bruynzeel, SS Oei, S Senan… - European Urology …, 2021 - Elsevier
Background The recent introduction of magnetic resonance-guided radiation therapy
(MRgRT) has allowed improved treatment planning and delivery of stereotactic body …
(MRgRT) has allowed improved treatment planning and delivery of stereotactic body …
相关搜索
- prostate cancer body radiotherapy
- magnetic resonance body radiotherapy
- magnetic resonance prostate cancer
- interim analysis body radiotherapy
- magnetic resonance interim analysis
- computed tomography body radiotherapy
- prostate cancer computed tomography
- prostate cancer mri linac
- prostate cancer interim analysis
- prostate cancer radiation therapy
- outcome and toxicity body radiotherapy
- magnetic resonance outcome and toxicity
- prostate cancer outcome and toxicity
- prostate cancer stereotactic radiotherapy
- meta analysis body radiotherapy
- magnetic resonance meta analysis